Chat with us, powered by LiveChat

Knee ACL Study Now Recruiting Patients

POSTED ON IN Knee Latest News Regenexx-ACL Research Studies and Clinical trials BY Chris Centeno

knee acl study

New Knee ACL study!  Introducing the Regenexx-ACL study.  If you have a torn knee ACL, you may be a candidate. We’ve been using injected stem cells to treat ACL injuries for years with good patient reported and MRI imaging results. However, we also want to test what we do using a more rigorous study design, a randomized controlled trial. This knee ACL study will enroll patients with partial or complete non-retracted ACL tears. Half will be randomized to the treatment using the Regenexx-ACL procedure, while the other half will get physical therapy exercises for three months. The procedure will be provided at no cost. At the end of the three months, the group that got the exercises will cross over into the treatment side and receive the stem cell injections. If you know someone with a bad ACL, have them contact us at [email protected] to see if they qualify for the study!

    *DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.
    Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.


    comments for this post are closed

    About the Author

    Chris Centeno

    Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine as well as rehabilitation and in pain management through The American Board of Physical Medicine and Rehabilitation.…

    View Profile

    Search Blog